Cargando…

Improving Outcomes for Patients With Advanced Urothelial Carcinoma

At JADPRO Live 2019, Petros Grivas, MD, PhD, and Jeannette Hammond, PA-C, reviewed data regarding mechanistic activity, efficacy, and safety of approved and emerging therapies for advanced or metastatic urothelial carcinoma, the selection of appropriate lines of therapy, and strategies for managing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grivas, Petros, Hammond, Jeannette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2020
Materias:	Meeting Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857332/ https://www.ncbi.nlm.nih.gov/pubmed/33598327 http://dx.doi.org/10.6004/jadpro.2020.11.3.14

Ejemplares similares

Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
por: Shah, Amishi, et al.
Publicado: (2018)

The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape
por: Koshkin, Vadim S., et al.
Publicado: (2019)

Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020)

Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
por: Koshkin, Vadim S., et al.
Publicado: (2021)

Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma
por: Joshi, Monika, et al.
Publicado: (2016)

Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes
por: Ten Eyck, Jennifer E, et al.
Publicado: (2022)

Improving Outcomes in Hematopoietic Stem Cell Transplant: Recent Advances
por: Alencar, Maritza
Publicado: (2021)

Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
por: Zhu, Alec, et al.
Publicado: (2023)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2018)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
por: Grivas, Petros, et al.
Publicado: (2018)

Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma(1)
por: Leiter, Amanda, et al.
Publicado: (2016)

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry
por: Peak, Taylor, et al.
Publicado: (2023)

Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status
por: Grivas, Petros, et al.
Publicado: (2020)

Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
por: Shadman, Mazyar, et al.
Publicado: (2020)

Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
por: Grivas, P., et al.
Publicado: (2023)

Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma
por: Fukuta, Kyotaro, et al.
Publicado: (2022)

Improving Outcomes for Patients With Metastatic Colorectal Cancer: Challenges and Strategies
por: Swanson, Leslie A., et al.
Publicado: (2020)

The 34th Annual Advances in Contrast Ultrasound International Bubble Conference, Chicago 2019: synopsis and take-home messages
por: Kyung, Stella, et al.
Publicado: (2020)

The 35th annual advances in contrast ultrasound international bubble conference, Chicago 2021: synopsis and take-home messages
por: Dunleavy, Michael, et al.
Publicado: (2022)

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
por: Powles, Thomas, et al.
Publicado: (2023)

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
por: Petros, Firas G.
Publicado: (2020)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma
por: Katims, Andrew B., et al.
Publicado: (2022)

Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer
por: Joshi, Monika, et al.
Publicado: (2020)

The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma
por: Hsieh, Meng-Che, et al.
Publicado: (2015)

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
por: Dietrich, Brian, et al.
Publicado: (2018)

Epilepsy Community at an Inflection Point: Translating Research Toward Curing the Epilepsies and Improving Patient Outcomes
por: Penn Miller, Ilene, et al.
Publicado: (2021)

Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?
por: DiMarco, Rose, et al.
Publicado: (2022)

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
por: Tagawa, Scott T., et al.
Publicado: (2021)

ATM/RB1 mutations predict shorter overall survival in urothelial cancer
por: Yin, Ming, et al.
Publicado: (2018)

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report
por: Küronya, Zsófia, et al.
Publicado: (2022)

Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
por: Lyou, Yung, et al.
Publicado: (2022)

Inherited mutations in Chinese patients with upper tract urothelial carcinoma
por: Wu, Junlong, et al.
Publicado: (2023)

Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes
por: Viereck, Amanda M., et al.
Publicado: (2020)

Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?
por: Sheridan, Paul O, et al.
Publicado: (2014)

Micropapillary Variant of Urothelial Carcinoma in a Hemodialysis Patient
por: Fukuta, Kyotaro, et al.
Publicado: (2022)

Development of synthetic cattle populations
por: Hammond, K
Publicado: (1982)

Development of synthetic cattle populations
por: Hammond, K
Publicado: (1982)

Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2015)

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma
por: Ning, Yang‐Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sa5kdfj3p2q476lkjrh1aerpan